Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.30
    OpenPayerPolicy UpdatesPharmacy & Specialty DrugsFlorida Medicaid EPANED Prior Auth | OpenPayer
    Ask Trek AI about this page
    CurrentAgency for Health Care AdministrationPolicy N/A

    EPANED (enalapril) oral solution coverage

    Customize your policy alerts

    Sign up for all Agency for Health Care Administration policy alerts

    Know when Agency for Health Care Administration releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy governs prior authorization for EPANED (enalapril) oral solution under Florida Medicaid fee-for-service. It applies to patients requiring treatment for hypertension, symptomatic heart failure, or asymptomatic left ventricular dysfunction who meet the specified age, preferred-alternative trial, and continuation requirements.

    Policy Summary
    PayerAgency for Health Care Administration
    PolicyEPANED (enalapril) oral solution coverage
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateN/A
    Next Review DateN/A
    Key ActionSubmit documentation of the qualifying diagnosis, patient age, and a documented trial and failure of the preferred alternative.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    Up to 1 yearMaximum authorization length
    1 month–11 yearsStandard eligible patient age range
    3Covered diagnostic indications listed
    1 mg/mLReady-to-use oral solution concentration

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Coverage Criteria

    Initial Therapy

    Covered when all required criteria are met.

    Initial therapy

    • Qualifying diagnosis

      • Patient has a diagnosis of hypertension.
      • Patient has symptomatic heart failure.
      • Patient has asymptomatic left ventricular dysfunction.

    • Applicable age or swallowing-difficulty criterion

      • Patient is one month to eleven years of age.
      • Patient is 12 or older and medical records indicate a history of difficulty swallowing (dysphagia), or a medical condition characterized by difficulty or inability to swallow.
    • Preferred alternative requirement: Patient has a documented trial and failure on the preferred alternative, such as enalapril oral solution.

    Continuation Therapy

    Continuation therapy is covered when all listed criteria are met.

    Continuation therapy

    • Initial criteria satisfied: Patient met initial review criteria.
    • Clinical response: Documentation shows a positive clinical response.
    • Appropriate dosing: Dosing is appropriate as per labeling or is supported by compendia.

    Prior Authorization and Documentation

    Prior Authorization

    Initial Prior Authorization Required

    Submit an initial prior authorization request for EPANED when the patient has a qualifying diagnosis, meets the applicable age or swallowing-difficulty requirement, and has a documented trial and failure on the preferred alternative.

    • Qualifying diagnoses: hypertension, symptomatic heart failure, or asymptomatic left ventricular dysfunction.
    • Patient is one month through 11 years of age; or, if age 12 or older, medical records document dysphagia or a medical condition characterized by difficulty or inability to swallow.
    • Documented trial and failure on the preferred alternative, such as enalapril oral solution.
    Prior Authorization

    Continuation Prior Authorization

    For continuation authorization, document that the patient met the initial review criteria, has demonstrated a positive clinical response, and is receiving an appropriate dose.

    • Patient met initial review criteria.
    • Documentation shows a positive clinical response.
    • Dosing is appropriate according to labeling or supported by compendia.
    Step Therapy

    Preferred Alternative Trial and Failure

    Document a trial and failure on the preferred alternative before requesting EPANED authorization.

    • The preferred alternative may include enalapril oral solution.
    • The record must identify the trial and document treatment failure.

    Unsupported block type: documentation

    Unsupported block type: documentation

    Unsupported block type: documentation

    Denial Risk

    Failure to Meet Initial Review Criteria

    Initial authorization may be denied when the qualifying diagnosis, applicable age or swallowing-difficulty requirement, or preferred-alternative trial-and-failure requirement is not met or documented.

    • No diagnosis of hypertension, symptomatic heart failure, or asymptomatic left ventricular dysfunction.
    • Patient is not one month through 11 years of age and, if age 12 or older, lacks documented dysphagia or a condition causing difficulty or inability to swallow.
    • No documented trial and failure on the preferred alternative, such as enalapril oral solution.
    Denial Risk

    Failure to Meet Continuation Criteria

    Continuation authorization may be denied when the patient did not meet the initial review criteria, a positive clinical response is not documented, or dosing is not appropriate or supported.

    • Initial review criteria were not met or are not documented.
    • Positive clinical response is not documented.
    • Dosing is inconsistent with labeling and is not supported by compendia.

    Policy Background

    This policy addresses prior authorization for EPANED (enalapril) oral solution for patients with hypertension, symptomatic heart failure, or asymptomatic left ventricular dysfunction. The product is available as a 1 mg/mL ready-to-use oral solution.

    Initial Therapy Criteria

    Initial Therapy

    Initial therapy requires all of the following criteria.

    Initial therapy

    • Qualifying diagnosis

      • Patient has a diagnosis of hypertension.
      • Patient has symptomatic heart failure.
      • Patient has asymptomatic left ventricular dysfunction.

    • Applicable age or swallowing-difficulty criterion

      • Patient is one month to eleven years of age.
      • Patient is 12 or older and medical records indicate a history of difficulty swallowing (dysphagia), or a medical condition characterized by difficulty or inability to swallow.
    • Preferred alternative requirement: Patient has a documented trial and failure on the preferred alternative, such as enalapril oral solution.

    Continuation Therapy Criteria

    Continuation Therapy

    Continuation therapy requires all listed criteria.

    Continuation therapy

    • Initial criteria satisfied: Patient met initial review criteria.
    • Clinical response: Documentation shows a positive clinical response.
    • Appropriate dosing: Dosing is appropriate as per labeling or is supported by compendia.

    Preferred Alternative Requirement

    StepRequirement
    1Documented trial and failure on the preferred alternative, such as enalapril oral solution.
    Policy Summary
    PayerAgency for Health Care Administration
    PolicyEPANED (enalapril) oral solution coverage
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateN/A
    Next Review DateN/A
    Key ActionSubmit documentation of the qualifying diagnosis, patient age, and a documented trial and failure of the preferred alternative.
    SourceLink
    On This Page
    Coverage CriteriaPrior Authorization and DocumentationPolicy BackgroundInitial Therapy CriteriaContinuation Therapy CriteriaPreferred Alternative Requirement